74 related articles for article (PubMed ID: 3935531)
1. Familial myeloma. A new observation in two distinct pairs of siblings.
Gobbi PG; Montecucco C; Trespi E; Cavalli C; Gendarini A; Bellotti V; Merlini G; Chèrie-Lignière EL; Ascari E
Haematologica; 1985; 70(4):324-8. PubMed ID: 3935531
[No Abstract] [Full Text] [Related]
2. Multiple myeloma in three siblings.
Horwitz LJ; Levy RN; Rosner F
Arch Intern Med; 1985 Aug; 145(8):1449-50. PubMed ID: 3927866
[TBL] [Abstract][Full Text] [Related]
3. Pleural involvement in multiple myeloma.
Airoldi M; Fantasia R; Giorgetti A; Stefanetti C
Haematologica; 1986; 71(1):56-9. PubMed ID: 3084359
[No Abstract] [Full Text] [Related]
4. Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes.
Giuliani N; Caramatti C; Roti G; Geata A; Colla S; Bonomini S; Hojden M; La Monica S; Sammarelli G; Lazzaretti M; Craviotto L; Mangoni L; Rizzoli V
J Clin Oncol; 2003 May; 21(9):1887-8. PubMed ID: 12721268
[No Abstract] [Full Text] [Related]
5. Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
Van Dobbenburgh OA; Houwen B; Piersma H; Marrink J; Ockhuizen T; Halie MR; Nieweg HO
Neth J Med; 1984; 27(2):25-30. PubMed ID: 6709108
[No Abstract] [Full Text] [Related]
6. Multiple myeloma: the National University Hospital (NUH) experience.
Lim HL; Teo CP; Wong K; Kuperan P; Suri R; Tan YO; Kueh YK
Singapore Med J; 1994 Aug; 35(4):371-3. PubMed ID: 7899894
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
[No Abstract] [Full Text] [Related]
8. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
9. [Indications for chemotherapy in multiple myeloma].
Heyll A; Aul C
Dtsch Med Wochenschr; 1996 May; 121(20):675. PubMed ID: 8635404
[No Abstract] [Full Text] [Related]
10. Multiple myeloma.
Bhattacharya SK; Singh NK; Srivastava PK; Tripathi K; Somani PN
J Indian Med Assoc; 1984 Nov; 82(11):394-7. PubMed ID: 6535796
[No Abstract] [Full Text] [Related]
11. Bortezomib in multiple myeloma: treatment and retreatment. A single center experience.
Warzocha K; Kraj M; Pogłód R; Kwaśniak B
Acta Pol Pharm; 2008; 65(6):753-6. PubMed ID: 19172860
[No Abstract] [Full Text] [Related]
12. Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma.
Kraut EH; Young D; Farag S; James AG; Solove RJ
Leuk Res; 2005 Oct; 29(10):1233-4. PubMed ID: 16111541
[No Abstract] [Full Text] [Related]
13. Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14).
Li JY; Wang LX; Shen WY; Lu SF; Chen LJ; Lu H
Leuk Res; 2009 Apr; 33(4):584-6. PubMed ID: 18829108
[No Abstract] [Full Text] [Related]
14. [Evaluation of the prognosis and response to therapy in multiple myeloma].
Venturino M; Geniram A; Guarino P; Scio P; Marini U
Recenti Prog Med; 1984 May; 75(5):451-61. PubMed ID: 6484288
[No Abstract] [Full Text] [Related]
15. Assessment of early paraprotein response to vincristine-doxorubicin-dexamethasone chemotherapy may help guide therapy in multiple myeloma.
Ross DM; To LB; Horvath N
Intern Med J; 2004; 34(9-10):576-8. PubMed ID: 15482273
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
[No Abstract] [Full Text] [Related]
17. [The influence of verapamil on platelet function in patients with multiple myeloma].
Sokołowska B; Dmoszyńska A; Walter-Croneck A; Wojtaszko M
Pol Merkur Lekarski; 1997 Feb; 2(8):109-10. PubMed ID: 9538652
[TBL] [Abstract][Full Text] [Related]
18. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation.
Weber DM
Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120
[TBL] [Abstract][Full Text] [Related]
19. Aberrant gene promoter methylation marking disease progression in multiple myeloma.
Chim CS; Liang R; Leung MH; Yip SF; Kwong YL
Leukemia; 2006 Jun; 20(6):1190-2. PubMed ID: 16598307
[No Abstract] [Full Text] [Related]
20. [IgM myeloma].
Assaf ME; Pizzolato MA; De María HE; Gasparini S; Burucua JE
Sangre (Barc); 1983; 28(5):642-7. PubMed ID: 6420914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
